17.01
price up icon0.00%   0.00
after-market アフターアワーズ: 17.06 0.05 +0.29%
loading
前日終値:
$17.01
開ける:
$16.99
24時間の取引高:
407.23K
Relative Volume:
0.65
時価総額:
$883.14M
収益:
$109.78M
当期純損益:
$114.54M
株価収益率:
7.7157
EPS:
2.2046
ネットキャッシュフロー:
$268.74M
1週間 パフォーマンス:
+0.53%
1か月 パフォーマンス:
+0.89%
6か月 パフォーマンス:
-10.76%
1年 パフォーマンス:
+22.29%
1日の値動き範囲:
Value
$16.97
$17.03
1週間の範囲:
Value
$16.93
$17.03
52週間の値動き範囲:
Value
$13.08
$21.03

Theravance Biopharma Inc Stock (TBPH) Company Profile

Name
名前
Theravance Biopharma Inc
Name
セクター
Healthcare (1033)
Name
電話
650-808-6000
Name
住所
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
Name
職員
90
Name
Twitter
Name
次回の収益日
2026-08-11
Name
最新のSEC提出書
Name
TBPH's Discussions on Twitter

Compare TBPH vs VRTX, REGN, ARGX, MRNA, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
TBPH icon
TBPH
Theravance Biopharma Inc
17.01 880.02M 109.78M 114.54M 268.74M 2.2046
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
547.59 136.93B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
828.50 85.11B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
1,011.11 64.95B 4.16B 1.29B 734.26M 19.58
MRNA icon
MRNA
Moderna Inc
138.89 53.23B 2.23B -3.19B -1.60B -8.1462
RVMD icon
RVMD
Revolution Medicines Inc
211.58 45.38B 742.00K -1.37B -1.07B -7.0731

Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-05 ダウングレード Oppenheimer Outperform → Perform
2026-03-04 ダウングレード B. Riley Securities Buy → Neutral
2025-12-03 開始されました Oppenheimer Outperform
2025-09-12 開始されました B. Riley Securities Buy
2024-08-06 ダウングレード Leerink Partners Outperform → Market Perform
2024-04-12 開始されました BTIG Research Buy
2024-01-08 ダウングレード Evercore ISI Outperform → In-line
2022-05-23 開始されました SVB Leerink Outperform
2021-11-05 アップグレード JP Morgan Underweight → Neutral
2021-09-15 ダウングレード JP Morgan Overweight → Underweight
2021-08-25 ダウングレード Morgan Stanley Overweight → Underweight
2021-08-24 ダウングレード Cowen Outperform → Market Perform
2020-10-14 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-07-07 開始されました JP Morgan Overweight
2020-06-15 開始されました Morgan Stanley Equal-Weight
2020-05-13 開始されました Cowen Outperform
2020-01-08 繰り返されました H.C. Wainwright Buy
2019-11-06 アップグレード Robert W. Baird Underperform → Neutral
2019-10-29 開始されました H.C. Wainwright Buy
2018-03-29 再開されました Piper Jaffray Overweight
2017-08-17 開始されました Evercore ISI Outperform
2017-06-16 開始されました Cantor Fitzgerald Overweight
2017-05-11 繰り返されました Needham Buy
2016-12-21 開始されました Needham Buy
2016-11-03 開始されました Piper Jaffray Overweight
2016-10-12 ダウングレード Robert W. Baird Neutral → Underperform
2016-08-03 ダウングレード BofA/Merrill Neutral → Underperform
2016-06-20 開始されました Guggenheim Buy
2016-06-20 繰り返されました Leerink Partners Outperform
2016-05-12 開始されました Leerink Partners Outperform
2016-05-05 ダウングレード BofA/Merrill Buy → Neutral
2015-02-03 アップグレード Robert W. Baird Underperform → Neutral
すべてを表示

Theravance Biopharma Inc (TBPH) 最新ニュース

pulisher
Aug 21, 2026

Theravance (NASDAQ: TBPH) sets vote on cash buyout with ampreloxetine CVR upside - Stock Titan

Aug 21, 2026
pulisher
Aug 20, 2026

Madison Avenue Partners, LP Trims Theravance Biopharma Inc (TBPH) Stake in Portfolio Rebalancing Move - GuruFocus

Aug 20, 2026
pulisher
Aug 19, 2026

Theravance Biopharma, Inc. Revenue Breakdown – NASDAQ:TBPH - TradingView

Aug 19, 2026
pulisher
Aug 19, 2026

Theravance Biopharma Inc (NASDAQ: TBPH) Share Price, TBPH Stock News, TBPH Share Price & Updates - Kalkine

Aug 19, 2026
pulisher
Aug 19, 2026

Theravance (TBPH) Update: Rises 0.18% to $16.98 on the Day; Price Setup: Traders Can Monitor the $16.13-$17.83 RangeSupport Level Bounce - vinanet.vn

Aug 19, 2026
pulisher
Aug 17, 2026

Theravance Biopharma (TBPH) Edges Higher to $16.97, Trapped Between Key Support and ResistanceFactor Valuation - vinanet.vn

Aug 17, 2026
pulisher
Aug 15, 2026

Theravance Biopharma Deal Faces Investor Probe - stl.news

Aug 15, 2026
pulisher
Aug 15, 2026

TBPH Stock Alert: Halper Sadeh LLC is Investigating Whether Theravance Biopharma, Inc. is Obtaining a Fair Price for its Shareholders - The AI Journal

Aug 15, 2026
pulisher
Aug 15, 2026

Wedge Capital Management L L P NC Buys Shares of 128,845 Theravance Biopharma, Inc. $TBPH - MarketBeat

Aug 15, 2026
pulisher
Aug 14, 2026

Theravance Biopharma (TBPH) Holds Steady at $16.97 as Traders Eye Range-Bound MoveCovered Call Trade - vinanet.vn

Aug 14, 2026
pulisher
Aug 14, 2026

Theravance Biopharma (TBPH): Newtyn discloses 6.7% holdings in amended 13G/A - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

Theravance Biopharma (TBPH) investor group reports 17.7% beneficial stake - Stock Titan

Aug 14, 2026
pulisher
Aug 13, 2026

(TBPH) Risk Channels and Responsive Allocation - Stock Traders Daily

Aug 13, 2026
pulisher
Aug 12, 2026

Theravance Biopharma (TBPH) Stock Caught Between Fading Gains And Royalty Doubts - Sahm

Aug 12, 2026
pulisher
Aug 11, 2026

Theravance Biopharma Announces Q2 2026 Financial Results with $10.8M Net Loss Amid Restructuring - Kalkine Media

Aug 11, 2026
pulisher
Aug 11, 2026

TBPH Meets Q2 Earnings Estimates, to be Acquired by Zymeworks - TradingView

Aug 11, 2026
pulisher
Aug 11, 2026

Theravance Biopharma (NASDAQ: TBPH) details $17 cash payout and ampreloxetine CVRs in Zymeworks deal - Stock Titan

Aug 11, 2026
pulisher
Aug 11, 2026

Theravance Biopharma, Inc. 2026: Revenue $20.73M, EPS ($0.11) — 10-Q Summary - TradingView

Aug 11, 2026
pulisher
Aug 11, 2026

Theravance Biopharma (TBPH) agrees $17 cash sale to Zymeworks plus CVRs - Stock Titan

Aug 11, 2026
pulisher
Aug 11, 2026

Renaissance Technologies LLC Acquires New Holdings in Theravance Biopharma, Inc. $TBPH - MarketBeat

Aug 11, 2026
pulisher
Aug 11, 2026

Israel Business NewsGlobes - Globes - Israel Business News

Aug 11, 2026
pulisher
Aug 11, 2026

Theravance Biopharma earnings missed by $0.17, revenue fell short of estimates - Investing.com Canada

Aug 11, 2026
pulisher
Aug 10, 2026

Theravance Biopharma Releases Q2 2026 Financial Results - AlphaStreet

Aug 10, 2026
pulisher
Aug 10, 2026

Theravance Biopharma Q2 net loss turns to USD 5.9 million; revenue rises 11% to USD 20.7 million YoY - Bitget

Aug 10, 2026
pulisher
Aug 10, 2026

Theravance Biopharma Q2 Results: Adj. EPS beats by 260% - scanx.trade

Aug 10, 2026
pulisher
Aug 10, 2026

Theravance Biopharma (NASDAQ:TBPH) Announces Quarterly Earnings Results, Meets Expectations - MarketBeat

Aug 10, 2026
pulisher
Aug 10, 2026

Form 8K Theravance Biopharma Inc For: 10 August By Investing.com - Investing.com Australia

Aug 10, 2026
pulisher
Aug 10, 2026

TBPH Looks 29.8% Undervalued on GF Value™ Amid Acquisition News - GuruFocus

Aug 10, 2026
pulisher
Aug 10, 2026

Theravance Biopharma Swings to Net Loss in Q2, Revenue Falls - marketscreener.com

Aug 10, 2026
pulisher
Aug 10, 2026

Earnings Flash (TBPH) Theravance Biopharma Posts Q2 Net Loss $0.11 a Share, vs. FactSet Est of $0.07 EPS - marketscreener.com

Aug 10, 2026
pulisher
Aug 10, 2026

Earnings Flash (TBPH) Theravance Biopharma, Inc. Reports Q2 Revenue $20.7M, vs. FactSet Est of $22.5M - marketscreener.com

Aug 10, 2026
pulisher
Aug 10, 2026

Theravance Biopharma Q2 2026: Viatris collaboration revenue $20.7M; net loss $5.9M; $388M cash - TradingView

Aug 10, 2026
pulisher
Aug 10, 2026

Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates - TradingView

Aug 10, 2026
pulisher
Aug 10, 2026

Theravance Bio: Q2 Earnings Snapshot - marketscreener.com

Aug 10, 2026
pulisher
Aug 10, 2026

BRIEF-Theravance Biopharma Q2 Operating Income USD -8.277 Million - TradingView

Aug 10, 2026
pulisher
Aug 10, 2026

THERAVANCE BIOPHARMA Q2 OPERATING INCOME USD -8.277 MILLION - Moomoo

Aug 10, 2026
pulisher
Aug 10, 2026

Press Release: Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Moomoo

Aug 10, 2026
pulisher
Aug 08, 2026

Theravance Biopharma, Inc. $TBPH Shares Acquired by Dimensional Fund Advisors LP - MarketBeat

Aug 08, 2026
pulisher
Aug 07, 2026

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Strong Revenue Growth and High ROE Offer Intriguing Investment Prospects - DirectorsTalk Interviews

Aug 07, 2026
pulisher
Aug 04, 2026

Theravance Biopharma (TBPH) Expected to Announce Earnings on Tuesday - MarketBeat

Aug 04, 2026
pulisher
Aug 03, 2026

Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Aug 03, 2026
pulisher
Aug 02, 2026

(TBPH) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Aug 02, 2026
pulisher
Aug 02, 2026

Theravance Biopharma (TBPH) Q1 2026 Earnings: 79.48% EPS Surprise Highlights Cost Discipline Amid Limited Top-Line VisibilityPre-Announcement Alert - vinanet.vn

Aug 02, 2026
pulisher
Aug 01, 2026

Swiss National Bank Invests $1.22 Million in Theravance Biopharma, Inc. $TBPH - MarketBeat

Aug 01, 2026
pulisher
Jul 31, 2026

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Evaluating a 4.85% Potential Upside Amidst Biotech Ambitions - DirectorsTalk Interviews

Jul 31, 2026
pulisher
Jul 31, 2026

Theravance Biopharma Inc (TBPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 31, 2026
pulisher
Jul 30, 2026

Theravance Biopharma (TBPH) Holds Steady Near Support as Trading Volume Remains MutedMomentum Surge Alerts - dars.gov.et

Jul 30, 2026
pulisher
Jul 29, 2026

TBPH Q2'26 Earnings: revenue estimate is 22.49M USD - TradingView

Jul 29, 2026
pulisher
Jul 27, 2026

ETFs Investing in Theravance Biopharma Inc Stocks - TradingView

Jul 27, 2026
pulisher
Jul 27, 2026

Theravance Biopharma Inc (TBPH) Cash Flow - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

TBPH|Theravance Biopharma Inc|Price:16.865|Chg%:+0.005 - TradingKey

Jul 27, 2026

Theravance Biopharma Inc (TBPH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Theravance Biopharma Inc (TBPH) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Samaha Eli
10% Owner
Jul 01 '26
Sale
17.00
37,799
642,628
9,174,453
Samaha Eli
10% Owner
Jun 30 '26
Sale
17.13
25,027
428,788
9,212,252
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Jun 15 '26
Sale
16.39
13,314
218,167
232,457
$123.98
price up icon 0.00%
$61.33
price up icon 0.03%
$112.82
price down icon 3.22%
$236.01
price down icon 0.09%
ONC ONC
$371.98
price down icon 0.66%
$211.58
price up icon 1.01%
大文字化:     |  ボリューム (24 時間):